SI Stock Forecast & Price Target

Shoulder Innovations Inc. reported a strong revenue increase of 58% year-over-year, achieving total revenues of $11.8 million for the fiscal year 2025, which exceeded estimates by $1.8 million. The company demonstrated impressive surgeon adoption of its implant portfolio, with core-contender surgeon customers growing approximately 61.4% year-over-year and a significant expansion in customer acquisition metrics, projecting the addition of 12 to 15 new customers each quarter. Furthermore, management raised the sales outlook for 2025 by about $2.5 million, anticipating total sales of $45 million to $46 million, reflecting a positive growth trajectory and sustained demand for its products.

Shoulder Innovations Inc. is experiencing significant financial challenges, highlighted by a reported adjusted EBITDA loss of $7.5 million, which exceeded previous modeling by approximately $400,000. The company's outlook is further hampered by multiple factors, including slower product uptake among new surgeons, lower shoulder market growth rates, and increased operating expenses, resulting in a total EBITDA loss of $23.6 million. Additionally, higher selling, general, and administrative costs, driven by increased headcount and legal expenses, have negatively impacted the company’s financial position.